DE10044846A1 - Mittel mit verlängerter Magenverweilzeit zur Erzeugung eines langanhaltenden Sättigungseffektes sowie dessen Verwendung - Google Patents
Mittel mit verlängerter Magenverweilzeit zur Erzeugung eines langanhaltenden Sättigungseffektes sowie dessen VerwendungInfo
- Publication number
- DE10044846A1 DE10044846A1 DE10044846A DE10044846A DE10044846A1 DE 10044846 A1 DE10044846 A1 DE 10044846A1 DE 10044846 A DE10044846 A DE 10044846A DE 10044846 A DE10044846 A DE 10044846A DE 10044846 A1 DE10044846 A1 DE 10044846A1
- Authority
- DE
- Germany
- Prior art keywords
- composition according
- fatty acids
- viscosity
- residence time
- long
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 230000000694 effects Effects 0.000 title claims abstract description 15
- 230000005923 long-lasting effect Effects 0.000 title claims abstract description 11
- 230000036186 satiety Effects 0.000 title claims abstract description 10
- 235000019627 satiety Nutrition 0.000 title claims abstract description 10
- 230000002496 gastric effect Effects 0.000 title claims description 6
- 230000002035 prolonged effect Effects 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 21
- 238000002360 preparation method Methods 0.000 claims abstract description 12
- 235000013305 food Nutrition 0.000 claims abstract description 10
- 239000000654 additive Substances 0.000 claims abstract description 4
- 230000000996 additive effect Effects 0.000 claims abstract description 4
- 239000002830 appetite depressant Substances 0.000 claims abstract description 3
- 235000015872 dietary supplement Nutrition 0.000 claims abstract description 3
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 24
- 239000000194 fatty acid Substances 0.000 claims description 24
- 229930195729 fatty acid Natural products 0.000 claims description 24
- 239000000126 substance Substances 0.000 claims description 22
- 150000004665 fatty acids Chemical class 0.000 claims description 21
- 239000000203 mixture Substances 0.000 claims description 21
- 239000007788 liquid Substances 0.000 claims description 12
- 210000002784 stomach Anatomy 0.000 claims description 10
- -1 compound fatty acids Chemical class 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 4
- 239000000243 solution Substances 0.000 claims description 4
- 229940053200 antiepileptics fatty acid derivative Drugs 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 239000007891 compressed tablet Substances 0.000 claims description 2
- 239000006185 dispersion Substances 0.000 claims description 2
- 239000008188 pellet Substances 0.000 claims description 2
- 229920001282 polysaccharide Polymers 0.000 claims description 2
- 239000005017 polysaccharide Substances 0.000 claims description 2
- 235000021395 porridge Nutrition 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 229920006395 saturated elastomer Polymers 0.000 claims description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 claims description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 claims description 2
- 150000004676 glycans Chemical class 0.000 claims 1
- 150000004671 saturated fatty acids Chemical class 0.000 claims 1
- 235000003441 saturated fatty acids Nutrition 0.000 claims 1
- 239000000499 gel Substances 0.000 description 8
- 229920002907 Guar gum Polymers 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 235000010417 guar gum Nutrition 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 235000002639 sodium chloride Nutrition 0.000 description 5
- 239000008119 colloidal silica Substances 0.000 description 4
- 239000000665 guar gum Substances 0.000 description 4
- 229960002154 guar gum Drugs 0.000 description 4
- 238000001665 trituration Methods 0.000 description 4
- 235000015099 wheat brans Nutrition 0.000 description 4
- 235000010443 alginic acid Nutrition 0.000 description 3
- 229920000615 alginic acid Polymers 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 239000000205 acacia gum Substances 0.000 description 2
- 150000001447 alkali salts Chemical class 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 239000002270 dispersing agent Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 239000003349 gelling agent Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000000416 hydrocolloid Substances 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- DBTMGCOVALSLOR-DEVYUCJPSA-N (2s,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](CO)O[C@H](O)[C@@H]2O)O)O[C@H](CO)[C@H]1O DBTMGCOVALSLOR-DEVYUCJPSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920000926 Galactomannan Polymers 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000206672 Gelidium Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000130592 Hibiscus syriacus Species 0.000 description 1
- 235000018081 Hibiscus syriacus Nutrition 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920001612 Hydroxyethyl starch Polymers 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 229920001543 Laminarin Polymers 0.000 description 1
- 239000005717 Laminarin Substances 0.000 description 1
- 229920001491 Lentinan Polymers 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 244000134552 Plantago ovata Species 0.000 description 1
- 235000003421 Plantago ovata Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000009223 Psyllium Substances 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000003868 ammonium compounds Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 235000012820 baking ingredients and mixes Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 230000030136 gastric emptying Effects 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940050526 hydroxyethylstarch Drugs 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 229940115286 lentinan Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 235000020124 milk-based beverage Nutrition 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229940070687 psyllium Drugs 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 210000001187 pylorus Anatomy 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/29—Mineral substances, e.g. mineral oils or clays
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/24—Cellulose or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Child & Adolescent Psychology (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10044846A DE10044846A1 (de) | 2000-09-11 | 2000-09-11 | Mittel mit verlängerter Magenverweilzeit zur Erzeugung eines langanhaltenden Sättigungseffektes sowie dessen Verwendung |
| DE20016260U DE20016260U1 (de) | 2000-09-11 | 2000-09-11 | Mittel mit verlängerter Magenverweilzeit zur Erzeugung eines langanhaltenden Sättigungseffektes |
| US10/363,090 US20030161885A1 (en) | 2000-09-11 | 2001-09-07 | Agent having prolonged stomach retention time used to produce a longlasting saturation effect, and the use thereof |
| AU2002210491A AU2002210491A1 (en) | 2000-09-11 | 2001-09-07 | Agent having prolonged stomach retention time used to produce a longlasting saturation effect, and the use thereof |
| CA002419389A CA2419389A1 (en) | 2000-09-11 | 2001-09-07 | Agent having prolonged stomach retention time used to produce a longlasting saturation effect, and the use thereof |
| EP01978347A EP1322182A2 (de) | 2000-09-11 | 2001-09-07 | Mittel mit verlängerter magenverweilzeit zur erzeugung eines langanhaltenden sättigungseffektes sowie dessen verwendung |
| JP2002524334A JP2004508310A (ja) | 2000-09-11 | 2001-09-07 | 胃での延長された滞留時間を有する、長時間保持される満腹効果を生じさせるための組成物およびその使用 |
| PCT/EP2001/010309 WO2002019842A2 (de) | 2000-09-11 | 2001-09-07 | Mittel mit verlängerter magenverweilzeit zur erzeugung eines langanhaltenden sättigungseffektes sowie dessen verwendung |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10044846A DE10044846A1 (de) | 2000-09-11 | 2000-09-11 | Mittel mit verlängerter Magenverweilzeit zur Erzeugung eines langanhaltenden Sättigungseffektes sowie dessen Verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE10044846A1 true DE10044846A1 (de) | 2002-04-04 |
Family
ID=7655784
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE10044846A Ceased DE10044846A1 (de) | 2000-09-11 | 2000-09-11 | Mittel mit verlängerter Magenverweilzeit zur Erzeugung eines langanhaltenden Sättigungseffektes sowie dessen Verwendung |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20030161885A1 (enExample) |
| EP (1) | EP1322182A2 (enExample) |
| JP (1) | JP2004508310A (enExample) |
| AU (1) | AU2002210491A1 (enExample) |
| CA (1) | CA2419389A1 (enExample) |
| DE (1) | DE10044846A1 (enExample) |
| WO (1) | WO2002019842A2 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10247910A1 (de) * | 2002-10-14 | 2004-04-22 | Beisel, Günther | Mittel zur Erzeugung eines langanhaltenden Sättigungseffektes |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1572238A1 (de) * | 2002-12-19 | 2005-09-14 | Günther Beisel | Mittel mit retardierter stofffreisetzung |
| WO2004056199A1 (de) * | 2002-12-19 | 2004-07-08 | Beisel Guenther | Zubereitung zur appetitminderung, sättigung und/oder gewichtsreduktion für kinder |
| EP3188713B2 (en) * | 2014-08-11 | 2024-04-10 | perora GmbH | Method of inducing satiety |
| LT3188717T (lt) * | 2014-08-11 | 2020-03-25 | Perora Gmbh | Vaisto forma, apimanti daleles |
| CA2989510A1 (en) | 2015-07-07 | 2017-01-12 | Perora Gmbh | Method of inducing satiety |
| AU2017220691A1 (en) | 2016-02-18 | 2018-08-09 | Perora Gmbh | Kits comprising satiety-inducing formulations |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5756450A (en) * | 1987-09-15 | 1998-05-26 | Novartis Corporation | Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutical excipients and novel cyclosporin galenic forms |
| US5855917A (en) * | 1996-12-04 | 1999-01-05 | Wisconsin Alumni Research Foundation | Method for controlling body fat and/or body weight in animals and pharmaceutical compositions for use therein comprising 20-carbon conjugated unsaturated fatty acids |
| US6054480A (en) * | 1997-09-18 | 2000-04-25 | Nectra, Inc. | Fatty acids as a diet supplement |
-
2000
- 2000-09-11 DE DE10044846A patent/DE10044846A1/de not_active Ceased
-
2001
- 2001-09-07 JP JP2002524334A patent/JP2004508310A/ja active Pending
- 2001-09-07 AU AU2002210491A patent/AU2002210491A1/en not_active Abandoned
- 2001-09-07 CA CA002419389A patent/CA2419389A1/en not_active Abandoned
- 2001-09-07 EP EP01978347A patent/EP1322182A2/de not_active Withdrawn
- 2001-09-07 US US10/363,090 patent/US20030161885A1/en not_active Abandoned
- 2001-09-07 WO PCT/EP2001/010309 patent/WO2002019842A2/de not_active Ceased
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10247910A1 (de) * | 2002-10-14 | 2004-04-22 | Beisel, Günther | Mittel zur Erzeugung eines langanhaltenden Sättigungseffektes |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002019842A3 (de) | 2007-11-15 |
| JP2004508310A (ja) | 2004-03-18 |
| CA2419389A1 (en) | 2003-02-20 |
| US20030161885A1 (en) | 2003-08-28 |
| AU2002210491A1 (en) | 2002-03-22 |
| WO2002019842A2 (de) | 2002-03-14 |
| EP1322182A2 (de) | 2003-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69107046T2 (de) | Algin enthaltende Nahrungsmittel und Getränke. | |
| DE69916288T2 (de) | Lipasehemmer und chitosan enthaltende arzneimittel | |
| US5118510A (en) | Niacin drink mix formulation | |
| DE68907835T3 (de) | Direkt verpressbare Füllstoffe zur verzögerten Freisetzung. | |
| US3974272A (en) | Palatable cholestyramine coacervate compositions | |
| DE69531900T2 (de) | Cerealien enthaltendes lebensmittel mit einem hohen gehalt an löslichen ballaststoffen | |
| DE69924999T2 (de) | Lipasehemmer enthaltende pharmazeutische zusammensetzungen | |
| US5932561A (en) | Dietary composition with lipid binding properties for weight management and serum lipid reduction | |
| JPH0745521B2 (ja) | 高血圧降下作用を有する高血圧降下剤 | |
| DE3406127A1 (de) | Diaet-faserprodukt | |
| DE60307249T2 (de) | Eisen-dextrin verbindung zur behandlung von anämien durch eisenmangel | |
| JP2010517542A (ja) | アルギン酸塩を含むダイエット食品 | |
| WO2003053451A1 (de) | Verwendung von ionischen und nichtionischen celluloseethern zur herstellung eines gelartigen mittels zur verhinderung der resorption von fetten aus dem magen-darm-trakt | |
| DE60022513T2 (de) | Verwendung eines fettsäure derivates in nasale gastrale enterale formulierungen | |
| Agrawal | Psyllium: a source of dietary fiber | |
| DE10044846A1 (de) | Mittel mit verlängerter Magenverweilzeit zur Erzeugung eines langanhaltenden Sättigungseffektes sowie dessen Verwendung | |
| DE60003556T2 (de) | Teilchenfoermige faserzusammensetzung | |
| JP2983716B2 (ja) | 水溶性食物繊維コンプレックスを含む食品組成物 | |
| DE20016260U1 (de) | Mittel mit verlängerter Magenverweilzeit zur Erzeugung eines langanhaltenden Sättigungseffektes | |
| CA2030448A1 (en) | Niacin drink mix formulation | |
| EP1383523B1 (de) | Kombinationspräparat zur behandlung des diabetes mellitus | |
| RU2251934C2 (ru) | Биологически активная пищевая добавка | |
| DE60216258T2 (de) | Pflanzensamenöl enthaltende zusammensetzung | |
| DE102006001035A1 (de) | Mittel für die perorale Applikation zur Verzögerung der Resorption von Stoffen | |
| DE1617273A1 (de) | Verfahren zur Herstellung von stabilen Furazolidon-Suspensionen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OP8 | Request for examination as to paragraph 44 patent law | ||
| 8131 | Rejection |